David Helekal
@dhelekal.bsky.social
76 followers 180 following 43 posts
Trees, Pathogens, Bayes. Current: Postdoc @ Harvard Chan SPH Prev: PhD @ Warwick
Posts Media Videos Starter Packs
✅ Say: "My manuscript has been metropolised"
❌ Don't say: "My manuscript has been rejected and so I've sent it to MDPI"
Reposted by David Helekal
Reposted by David Helekal
yhgrad.bsky.social
A fun conversation with Carl this afternoon about his excellent book AIR-BORNE--the recording is available at the HSPH youtube site: www.youtube.com/user/Harvard...
Reposted by David Helekal
senjutisaha.bsky.social
One ceftriaxone-resistant #typhoid case last year set us on a path that is now live on Emerging Infectious Diseases.
47 cases in months, resistance rose from 0 to 5%. We spoke with patients, sequenced samples. 4.3.1.2.B1 lineage+blaCTX-M-15 on pCROB1. #AMR #PublicHealth
wwwnc.cdc.gov/eid/article/...
Outbreak of Ceftriaxone-Resistant <em>Salmonella enterica</em> Serovar Typhi, Bangladesh, 2024
Ceftriaxone-Resistant <em>Salmonella</em> Typhi, Bangladesh
wwwnc.cdc.gov
Reposted by David Helekal
(9/10) As N. gonorrhoeae strains carrying high-level cephalosporin resistance on a tetM positive background have been emerging globally wwwnc.cdc.gov/eid/article/..., the evident strength of selection for tetM may have created a favorable environment for their expansion in the US.
Emergence of Extensively Drug-Resistant <em>Neisseria gonorrhoeae,</em> France, 2023
Extensively Drug-Resistant <em>Neisseria gonorrhoeae</em>
wwwnc.cdc.gov
(8/10) This raises concern for genetic hitchhiking, whereby alleles that may be neutral or deleterious on their own actually increase in frequency due to their presence in lineages that carry another gene or allele that’s beneficial.
(7/10) The number of major N. gonorrhoeae lineages carrying tetM also increased from one before 2020 that accounted for ~40% of all tetM+ isolates to 4 after 2020 that collectively accounted for ~80% of all tetM+ isolates. Two of these lineages carry penA variants that increase cephalosporin MICs.
(5/10) By May 2024, the estimated proportion of isolates carrying tetM skyrocketed to ~35%, suggesting a large selective pressure for doxycycline resistance. The rise seems most pronounced in HHS regions 9 and 10.
(4/10) To investigate the impact of the increased doxy use, we analyzed a collection of over 14000 N. gonorrhoeae genomes spanning 2018-mid 2024, collected and sequenced through CDC surveillance efforts -- GISP, eGISP, SURRG www.cdc.gov/gonorrhea/hc....
Drug-Resistant Gonorrhea
This page explains drug-resistant gonorrhea, changing treatments, and current challenges
www.cdc.gov
(2/10) Over the past few years, the use of doxycycline to treat bacterial STIs has gone up in the US. Doxy became the recommended treatment for chlamydia (2020), it was used for syphilis treatment during bicillin shortages, and doxy-PEP was rolled out. What’s the impact on resistance?
(1/10) New preprint: Expansion of tetM-carrying Neisseria gonorrhoeae in the US, 2018-2024; Link: www.medrxiv.org/content/10.1...
(9/10) As N. gonorrhoeae strains carrying high-level cephalosporin resistance on a tetM positive background have been emerging globally wwwnc.cdc.gov/eid/article/..., the evident strength of selection for tetM may have created a favorable environment for their expansion in the US.
Emergence of Extensively Drug-Resistant <em>Neisseria gonorrhoeae,</em> France, 2023
Extensively Drug-Resistant <em>Neisseria gonorrhoeae</em>
wwwnc.cdc.gov
(8/10) This raises concern for genetic hitchhiking, whereby alleles that may be neutral or deleterious on their own actually increase in frequency due to their presence in lineages that carry another gene or allele that’s beneficial.
(7/10) The number of major N. gonorrhoeae lineages carrying tetM also increased from one before 2020 that accounted for ~40% of all tetM+ isolates to 4 after 2020 that collectively accounted for ~80% of all tetM+ isolates. Two of these lineages carry penA variants that increase cephalosporin MICs.
(5/10) By May 2024, the estimated proportion of isolates carrying tetM skyrocketed to ~35%, suggesting a large selective pressure for doxycycline resistance. The rise seems most pronounced in HHS regions 9 and 10.
(4/10) To investigate the impact of the increased doxy use, we analyzed a collection of over 14000 N. gonorrhoeae genomes spanning 2018-mid 2024, collected and sequenced through CDC surveillance efforts -- GISP, eGISP, SURRG www.cdc.gov/gonorrhea/hc....
Drug-Resistant Gonorrhea
This page explains drug-resistant gonorrhea, changing treatments, and current challenges
www.cdc.gov
(3/10) This is especially relevant for N. gonorrhoeae. In 2018, an estimated 10% of isolates carried the plasmid-borne gene tetM, which confers high-level tetracycline resistance (MIC ≥ 16 µg/mL).